Physician profile
Walter J Rhoades
NPI 1730152943
$331.28
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.34 · 2020: $14.87 · 2021: $40.16 · 2022: $88.78 · 2023: $134 · 2024: $28.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $73.25 | 2022-2024 | Aristada, Lybalvi |
| Abbvie INC. | $69.53 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $54.59 | 2022-2023 | Abilify Maintena |
| Janssen Pharmaceuticals, INC | $47.10 | 2019-2023 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $29.56 | 2022-2023 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $16.32 | 2022 | |
| Indivior INC. | $14.87 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.63 | 2023 | |
| Vanda Pharmaceuticals INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.